Adaptimmune (ADAPY) SEC Filings https://www.adaptimmune.com/investors-and-media/sec-filings/section-16-filings/rss Adaptimmune (ADAPY) - Section 16 Filings en-us https://d1io3yog0oux5.cloudfront.net/adaptimmune/files/theme/images/logo-sm.png Adaptimmune Logo https://www.adaptimmune.com Equisolve Investor Relations Suite <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2242-0001104659-25-098032 Wed, 08 Oct 25 21:00:40 -0400 https://www.adaptimmune.com/section-16-filings?page=1#document-2242-0001104659-25-098032 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2237-0001104659-25-087085 Wed, 03 Sep 25 17:00:51 -0400 https://www.adaptimmune.com/section-16-filings?page=1#document-2237-0001104659-25-087085 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2235-0001104659-25-085820 Fri, 29 Aug 25 18:26:03 -0400 https://www.adaptimmune.com/section-16-filings?page=1#document-2235-0001104659-25-085820 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2230-0000950170-25-110254 Tue, 19 Aug 25 19:07:37 -0400 https://www.adaptimmune.com/section-16-filings?page=1#document-2230-0000950170-25-110254 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2205-0000935836-25-000476 Wed, 30 Jul 25 18:21:17 -0400 https://www.adaptimmune.com/section-16-filings?page=1#document-2205-0000935836-25-000476 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2168-0001104659-25-015746 Thu, 20 Feb 25 17:36:03 -0500 https://www.adaptimmune.com/section-16-filings?page=1#document-2168-0001104659-25-015746 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2167-0001104659-25-015745 Thu, 20 Feb 25 17:35:17 -0500 https://www.adaptimmune.com/section-16-filings?page=1#document-2167-0001104659-25-015745 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2166-0001104659-25-015743 Thu, 20 Feb 25 17:34:05 -0500 https://www.adaptimmune.com/section-16-filings?page=1#document-2166-0001104659-25-015743 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2165-0001104659-25-015742 Thu, 20 Feb 25 17:32:59 -0500 https://www.adaptimmune.com/section-16-filings?page=1#document-2165-0001104659-25-015742 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.adaptimmune.com/section-16-filings?page=1#document-2164-0001104659-25-015741 Thu, 20 Feb 25 17:32:13 -0500 https://www.adaptimmune.com/section-16-filings?page=1#document-2164-0001104659-25-015741